PATENT CLAIM ANALYSIS

Application Number: 16412091
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "210210"]

Abstract:
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Claim (Index 6):
The method of  claim 5 , wherein the therapeutically effective amount of the compound is between about 0.1 to 50 mg/kg per day.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 100.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15814279', '16191190', '16173726', '13586814', '13948342']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.815137682342753
- 35 USC 102 Novelty (BERT): 0.6286677408901797
- Combined Prediction Score: 0.7964906881974957
- Mean Citation Score: 450.776984
- Max Citation Score: 570.5313
- Similarity Product: 568.8670309209107

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test